Is There a Wegovy Tablet? What Is Actually Available in the UK

• Answers the Wegovy tablet question directly, with what the UK register actually lists
• Explains why anything sold as a Wegovy pill is a warning sign, not a bargain
• Sets out the needle free options that genuinely exist on prescription here
• Covers how to use the injection and how a tablet differs in practice

Yes. Wegovy is available in both tablet and injection forms in the UK, following the MHRA's approval of the oral semaglutide tablet in June 2026.

Both contain semaglutide, but they are taken differently and have different instructions for use. The tablet is taken daily on an empty stomach, while the injection is administered once a week.

If you are considering a tablet instead of an injection, it is important to understand the differences, check whether treatment is suitable for you and obtain prescription medicines through a legitimate pharmacy.

Key things to know

• Wegovy is available as a once-weekly injection and an authorised oral tablet in the UK.
• The tablet contains semaglutide and has its own dosing instructions.
• Oral Wegovy is not interchangeable with other oral GLP-1 medicines.
• Both formulations require a prescription and appropriate clinical assessment.
• Avoid buying weight-management medicines from unregulated sellers or without a valid prescription.

Is Wegovy available in tablet form?

Yes. The MHRA approved Wegovy tablets for weight loss and weight management in the UK on 11 June 2026.

The tablet contains semaglutide, the same active ingredient used in Wegovy injections, but it is formulated for oral use. It has a separate dosing schedule and specific instructions to help the body absorb the medicine.

The tablet is taken once daily, whereas the injection is administered once a week. Neither formulation should be substituted for the other without guidance from the prescribing clinician.

The tablet's approval does not mean it is suitable for everyone. A healthcare professional should assess eligibility, medical history, current medicines and potential risks before prescribing it.

What forms does Wegovy come in?

Wegovy is available in two formulations in the UK:

• Tablet: Taken once daily, following the specific instructions for oral semaglutide.
• Injection: Administered once a week using a pre-filled injection pen.

The two formulations have different dosing schedules, administration instructions and storage requirements. Follow the patient information leaflet for the product prescribed to you.

Why so many people search for a Wegovy pill

Four reasons, and none of them is unreasonable.

The first is needle aversion, which is extremely common and frequently underestimated. A genuine fear of needles stops people starting treatment they would otherwise benefit from, and it is a legitimate clinical consideration rather than squeamishness.

The second is that oral GLP-1 medicines genuinely exist, so people reasonably assume the brand they have heard of must have one.

The third is that search results are full of pages offering Wegovy tablets, which makes the product seem real. Those pages are the problem, and they are the reason this article opens the way it does.

There is a fourth reason worth naming, which is that people often want the brand they have heard of rather than a medicine they have not. That is an entirely human instinct and it is also the one that unlicensed sellers rely on. Familiarity with a name is not evidence that a particular product exists.

If injections are a barrier for you, ask your prescriber whether an oral weight-management medicine may be suitable. Oral Wegovy is now authorised in the UK, but suitability depends on your medical history, eligibility and the treatment's specific requirements.

How to identify potentially unsafe Wegovy products

The approval of oral Wegovy does not mean every product advertised online is genuine or supplied appropriately.

Before obtaining treatment, make sure that the medicine is prescribed following an appropriate clinical assessment and dispensed through a legitimate pharmacy. Avoid sellers offering prescription medicines without the required prescription or clinical checks.

Do not rely on packaging, online reviews or claims of unusually low prices to establish authenticity. If you suspect that a medicine is counterfeit or unlicensed, do not take it and seek advice from a pharmacist or healthcare professional.

If you have already taken a product that may be counterfeit and feel unwell, seek medical advice. Suspected adverse reactions to medicines can also be reported through the MHRA Yellow Card scheme.

The test you can apply yourself

A medicine can only be supplied in the UK in the forms its marketing authorisation covers. Wegovy's covers an injection. Therefore:

1. Check whether the medicine and formulation are authorised in the UK.
2. Obtain prescription medicines through a legitimate pharmacy with the required prescription and clinical assessment.
3. If the product's identity, ingredients or source cannot be verified, do not take it.

That reasoning holds regardless of how professional the website looks, how many reviews it displays, or how the packaging is photographed. You do not need to be able to spot a fake. You only need to know that the genuine article does not exist in that form.

What the MHRA says about buying these medicines

The MHRA is explicit that GLP-1 medicines should not be bought from unregulated sellers such as beauty salons or via social media, or from anywhere without a prior consultation with a healthcare professional. It also confirms that all GLP-1 medicines are prescription only, which means they can only be prescribed by a healthcare professional.

Falsified weight loss products are a live enforcement issue rather than a theoretical risk, and the pattern is consistent: where demand runs ahead of legitimate supply, counterfeit product appear to fill the gap. A brand that does not exist in tablet form is the easiest gap of all to exploit, because there is no genuine product to compare against.

If you have already bought something sold as a Wegovy tablet

Do not take it, and do not take any more of it if you have already started. There is no way to establish what is in an unlicensed product from looking at it, and the risk is not limited to it being ineffective. Products of this kind have been found to contain the wrong substance entirely, the wrong amount, or contaminants.

If you have taken some and feel unwell, seek medical advice and say what you took and where it came from. Nobody will be interested in telling you off, and the information genuinely helps. If you have had a reaction to something you believe was sold as a medicine, it can be reported through the MHRA Yellow Card scheme.

It is also worth telling your prescriber at your assessment. It changes nothing about your eligibility, and it gives them relevant information about what has already been in your system.

What weight-management tablets are available in the UK?

Oral Wegovy (semaglutide) is authorised in the UK for weight loss and weight management in eligible adults. It is taken once daily and has specific instructions regarding fasting, water intake and the waiting period before eating or drinking.

Foundayo (orforglipron) is another oral GLP-1 medicine authorised in the UK for weight management. Unlike oral semaglutide, it can be taken at any time of day without the same food or water restrictions.

These medicines are not interchangeable. They contain different active ingredients and have their own dosing schedules, safety information and prescribing requirements.

A prescriber should determine which medicine, if any, is appropriate for an individual. Do not switch between products or follow dosing instructions intended for another medicine.

How an oral GLP-1 differs from a weekly injection in practice

Is oral GLP-1 the same as the Wegovy injection?

Both formulations contain semaglutide, but they are designed for different routes of administration and have different dosing instructions.

Oral semaglutide must be taken under specific fasting conditions to support absorption. The injection is administered once a week and does not require the same daily routine.

Other oral GLP-1 medicines may work through the same receptor but contain different active ingredients. Their effectiveness and safety should not be assumed to match those of Wegovy.

Your prescriber can explain the differences and help determine which option is appropriate for you.

Tablet or injection: how to choose

Neither format is the right answer in general. It is a practical question about how you live.

A daily tablet tends to suit

• People for whom needles are a genuine barrier rather than a mild dislike.
• People with a stable morning routine who will reliably wait before breakfast.
• People who travel often and would rather not manage refrigeration and sharps.
• People who would find one missed dose out of seven less alarming than one missed week.

A weekly injection tends to suit

• People who would rather deal with treatment once and forget about it for six days.
• People whose mornings are unpredictable or who eat at irregular times.
• Shift workers, whose daily timings shift but whose weekly rhythm does not.
• People who already manage other injections comfortably.

To see the full set of licensed options alongside each other and what each one involves, you can review all the licensed weight loss options in one place before your assessment.

How to use the Wegovy injection

The authority on this is the patient information leaflet supplied with your pen, and the training you are given when you start. What follows is the general shape, with no dose information, because doses are set by your prescriber.

Where the injection goes

Into the fat layer just under the skin, using the pen's short fine needle. The usual sites are the abdomen, the front of the thigh and the back of the upper arm.

Rotate the site each week rather than using the same spot repeatedly, which gives the tissue time to recover and reduces lumps and soreness. Avoid injecting into skin that is bruised, tender, hard, scarred or broken.

Practical points that make it easier

• Let the pen come to room temperature before injecting. Cold liquid stings noticeably more.
• Use a new needle every time. A reused needle is blunt and causes more trauma and more bruising.
• Do not rub the site afterwards. Light pressure with a clean tissue is enough.
• Pick one day of the week and keep it, because a fixed day is easier to protect than a rough intention.
• A small bruise is common and simply means the needle passed through a tiny blood vessel.

Storage and sharps

Unopened pens usually require refrigeration, with different storage rules once a pen is in use. The leaflet gives exact temperatures and time limits, and these matter because the medicine is a peptide and is sensitive to heat.

Used needles and pens go into a sharps bin, never into household waste or recycling. Your supplying pharmacy can advise on obtaining one and on disposal.

Missed dose

Follow the patient information leaflet, which sets out what to do and within what window. The rule that applies to every medicine in this class is that you never take two doses to make up for a missed one.

If you are unsure, contact the prescribing service rather than guessing.

How oral GLP-1 medicines are taken

Administration instructions depend on the medicine.

Oral Wegovy (semaglutide) must be taken on an empty stomach after at least eight hours of fasting, with a small amount of water. You must then wait at least 30 minutes before eating, drinking or taking other oral medicines.

Foundayo (orforglipron), by contrast, can be taken at any time of day without the same food or water restrictions.

Always follow the patient information leaflet supplied with your prescribed medicine. Do not apply the instructions for one tablet to another.

Needle free weight loss options in the UK

What genuinely counts

Oral GLP-1 treatment is the main needle free option in this class, available on prescription after an assessment. A medicine that reduces the amount of fat absorbed from food is also available and is taken as a capsule with meals, working by a completely different mechanism.

Both are prescription only. Both require the same assessment process, the same eligibility criteria based on BMI and weight related conditions, and the same prescriber decision.

What does not count

Supplements, fat burners, detox products, patches, drops and anything described as a natural alternative are not GLP-1 medicines and do not contain one. They are not assessed by the MHRA as medicines, and claims made for them are not held to the standard a licensed medicine must meet.

The distinction is not a technicality about paperwork. A licensed medicine has had its evidence, its manufacturing and its safety profile examined by a regulator before it reached you, and it arrives with approved information telling you what it does, what it might do to you and who should avoid it. A supplement has had none of that, whatever the packaging implies.

NICE positions weight management medicines as something to consider after dietary, exercise and behavioural approaches have been started and evaluated, and states that all medicines for weight management should be used alongside a reduced calorie diet and increased physical activity. That applies whichever format you end up using. Weight loss support whichever format you choose is the part that decides what happens over the following year.

Getting treatment safely

A legitimate UK service takes a full medical history including your other medicines and conditions, verifies your identity and measurements rather than accepting whatever is typed in, has a prescriber review your request individually, dispenses from a pharmacy registered with the GPhC, and includes the approved patient information leaflet with your medicine.

If a supplier is offering a form of a medicine that does not exist, none of those steps is happening. Suspected side effects from any licensed medicine can be reported through the MHRA Yellow Card scheme, and you do not need to be certain the medicine caused the problem to report it.

Medical Disclaimer

This article is general information about prescription only medicines and is not medical advice. It contains no dosing instructions and no dose escalation schedule, and it is not a substitute for a consultation with a qualified healthcare professional. These medicines should only be used under the supervision of an appropriately qualified prescriber and in line with the approved patient information leaflet supplied with your medicine.

Treatment suitability depends on an individual clinical assessment, and results vary between individuals. Seek urgent medical attention for severe or persistent abdominal pain, repeated vomiting, sudden changes in vision, or signs of an allergic reaction such as swelling of the face, lips or throat or difficulty breathing. Suspected side effects can be reported through the MHRA Yellow Card scheme.